{
    "eid": "2-s2.0-85086775938",
    "title": "Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson\u2019s disease management in developing countries",
    "cover-date": "2020-06-02",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuroscience (all)",
            "@code": "2800",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "apomorphine infusion",
        "developing countries",
        "device-aided therapy",
        "motor complications",
        "Parkinson\u2019s disease",
        "Parkinson\u2019s disease nurse specialists",
        "specialist centers",
        "Thailand",
        "treatment accessibility"
    ],
    "authors": [
        "Roongroj Bhidayasiri",
        "Onanong Phokaewvarangkul",
        "Karn Sakdisornchai",
        "Kamolwan Boonpang",
        "K. Ray Chaudhuri",
        "Jan Parsons",
        "Praween Lolekha",
        "Parnsiri Chairangsaris",
        "Prachaya Srivanitchapoom",
        "Sharon Benedierks",
        "Pattamon Panyakaew",
        "Thanatat Boonmongkol",
        "Yuwadee Thongchuam",
        "Nitinan Kantachadvanich",
        "Saisamorn Phumphid",
        "Andrew H. Evans",
        "Akravudh Viriyavejakul",
        "Apichart Pisarnpong",
        "Teus van Laar",
        "Priya Jagota"
    ],
    "citedby-count": 4,
    "ref-count": 88,
    "ref-list": [
        "Forecasting imbalances of human resources for health in the Thailand health service system: application of a health demand method",
        "The political economy of UHC reform in Thailand: lessons for low- and middle-income countries",
        "Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030",
        "Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016",
        "The emerging evidence of the Parkinson pandemic",
        "Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities",
        "A national registry to determine the distribution and prevalence of Parkinson\u2019s disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson\u2019s disease",
        "Paraquat exposure and Parkinson\u2019s disease: a systematic review and meta-analysis",
        "Knowledge of Parkinson\u2019s disease in a multiethnic urban asian setting",
        "Unmet needs in Parkinson\u2019s disease: new horizons in a changing landscape",
        "Gastrointestinal dysfunction in Parkinson\u2019s disease",
        "Gastrointestinal dysfunction in Parkinson\u2019s disease",
        "Non-oral dopaminergic therapies for Parkinson\u2019s disease: current treatments and the future",
        "New hopes for disease modification in Parkinson\u2019s disease",
        "The modern pre-levodopa era of Parkinson\u2019s disease: insights into motor complications from sub-Saharan Africa",
        "Risk and course of motor complications in a population-based incident Parkinson\u2019s disease cohort",
        "Advanced Parkinson\u2019s or \u201ccomplex phase\u201d Parkinson\u2019s disease? Re-evaluation is needed",
        "Adjunctive therapies in Parkinson\u2019s disease: how to choose the best treatment strategy approach",
        "Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson\u2019s disease: a multi-country Delphi-panel approach",
        "Unmet needs of people with Parkinson\u2019s disease: a cross-sectional study",
        "Parkinson\u2019s family needs and caregiver mental health: a cross-cultural comparison between Mexico and the United States",
        "Experiences of health services and unmet care needs of people with late-stage Parkinson\u2019s in England: a qualitative study",
        "Delivering patient-centered care in Parkinson\u2019s disease: challenges and consensus from an international panel",
        "Multidisciplinary care in Parkinson\u2019s disease",
        "Effectiveness of multidisciplinary care for Parkinson\u2019s disease: a randomized, controlled trial",
        "A census of movement disorders at a Thai university hospital",
        "Integrated multidisciplinary care in Parkinson\u2019s disease: a non-randomised, controlled trial (IMPACT)",
        "Inpatient enhanced multidisciplinary care effects on the quality of life for Parkinson disease: a quasi-randomized controlled trial",
        "The cost-effectiveness of specialized nursing interventions for people with Parkinson\u2019s disease: the NICE-PD study protocol for a randomized controlled clinical trial",
        "A guideline for Parkinson\u2019s disease nurse specialists, with recommendations for clinical practice",
        "Neurologist care in Parkinson disease: a utilization, outcomes, and survival study",
        "Neurologist-associated reduction in PD-related hospitalizations and health care expenditures",
        "Availability of anti-parkinsonian drugs in Thailand",
        "Asian perspectives on the recognition and management of levodopa \u2018wearing-off\u2019 in Parkinson\u2019s disease",
        "Treatment of Parkinson\u2019s disease in Thailand: review of the literature and practical recommendations",
        "SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson\u2019s disease",
        "Medical and surgical management of advanced Parkinson\u2019s disease",
        "Expert consensus group report on the use of apomorphine in the treatment of Parkinson\u2019s disease\u2013clinical practice recommendations",
        "Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses",
        "Apomorphine hydrochloride for the treatment of Parkinson\u2019s disease",
        "Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson\u2019s disease: long-term follow-up study of 64 patients",
        "Pharmacological insights into the use of apomorphine in Parkinson\u2019s disease: clinical relevance",
        "Apomorphine - pharmacological properties and clinical trials in Parkinson\u2019s disease",
        "Apomorphine subcutaneous infusion in patients with Parkinson\u2019s disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial",
        "International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease",
        "Apomorphine infusion in advanced Parkinson disease",
        "Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson\u2019s disease",
        "Non-oral continuous drug delivery techniques in Parkinson\u2019s disease: for whom, when, and how?",
        "Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson\u2019s disease: consensus from an international survey and discussion program",
        "Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy",
        "EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson\u2019s disease",
        "Understanding the role of the Parkinson\u2019s disease nurse specialist in the delivery of apomorphine therapy",
        "Long-term apomorphine infusion users versus short-term users: an international dual-center analysis of the reasons for discontinuing therapy",
        "Clinical insights into use of apomorphine in Parkinson\u2019s disease: tools for clinicians",
        "Practical approaches to commencing device-assisted therapies for Parkinson disease in Australia",
        "Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson\u2019s disease with motor fluctuations: a multicenter study",
        "Practical management of adverse events related to apomorphine therapy",
        "Cutaneous side effects of infused apomorphine: the patient and carer experience",
        "Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson\u2019s disease patients",
        "Continuous subcutaneous apomorphine infusion in advanced Parkinson\u2019s disease: 10-year experience with 230 patients",
        "Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study",
        "Parkinson\u2019s disease in the Western Pacific Region",
        "Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: results of an online survey",
        "Personalized medicine in Parkinson\u2019s disease: time to be precise",
        "Knowledge, attitudes and perceptions of Parkinson\u2019s disease: a cross-sectional survey of Asian patients",
        "Identifying gaps in knowledge about Parkinson disease among medical professionals in Thailand",
        "Primary health care providers\u2019 knowledge gaps on Parkinson\u2019s disease",
        "Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson\u2019s disease patients",
        "The management of Parkinson\u2019s disease in sub-Saharan Africa",
        "Direct costs of managing Parkinson\u2019s disease in India: concerns in a developing country",
        "Average annual cost of Parkinson\u2019s disease in Sao Paulo, Brazil, with a focus on disease-related motor symptoms",
        "Multidisciplinary care for people with Parkinson\u2019s disease: the new kids on the block!",
        "Multidisciplinary care of patients with Parkinson\u2019s disease",
        "Evaluation of a Regional Australian Nurse-Led Parkinson\u2019s Service Using the Context, Input, Process, and Product Evaluation Model",
        "Parkinson\u2019s disease: symptoms, treatment options and nursing care",
        "Parkinson\u2019s nurses: a light in the darkness",
        "Moving from physician-centered care towards patient-centered care for Parkinson\u2019s disease patients",
        "Understanding patients\u2019 and caregivers\u2019 perspectives and educational needs in Parkinson\u2019s disease: a multi-ethnic Asian study",
        "A U.S. survey of patients with Parkinson\u2019s disease: satisfaction with medical care and support groups",
        "The relationship between Parkinson\u2019s disease symptoms and caregiver quality of life",
        "Caregiver burden and its related factors in advanced Parkinson\u2019s disease: data from the PREDICT study",
        "The impact of the nocturnal disabilities of Parkinson\u2019s disease on caregivers\u2019 burden: implications for interventions",
        "Old Drugs, New Delivery Systems in Parkinson\u2019s Disease",
        "A roadmap for implementation of patient-centered digital outcome measures in Parkinson\u2019s disease obtained using mobile health technologies",
        "The promise of telemedicine for movement disorders: an interdisciplinary approach"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60031451",
            "affilname": "Thammasat University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031451",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "@id": "60021923",
            "affilname": "King's College Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021923",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020921",
            "affilname": "The Walton Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020921",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Groningen",
            "@id": "60010023",
            "affilname": "Rijksuniversiteit Groningen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010023",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60005245",
            "affilname": "Royal Melbourne Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005245",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": null,
            "@id": "60004592",
            "affilname": "Prasat Neurological Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004592",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "124622883",
            "affilname": "Stada Pharmaceuticals",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124622883",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "106959129",
            "affilname": "Phramongkutklao Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106959129",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Association",
        "Britannia Pharmaceuticals Limited",
        "Chulalongkorn Academic Advancement Fund",
        "Medizin Akademie Organisationsteam",
        "Stada Thailand Pharmaceuticals Limited",
        "Thailand Science",
        "Thailand Science Research and Innovation",
        "Boehringer-Ingelheim",
        "Abbott",
        "Newton Fund",
        "Chulalongkorn University",
        "National Science and Technology Development Agency",
        "Thailand Research Fund"
    ]
}